Correlation Engine 2.0
Clear Search sequence regions

  • adult (1)
  • Alpha2 (1)
  • child (1)
  • child preschool (1)
  • cohort (2)
  • collagen (2)
  • female (1)
  • humans (1)
  • institutes (1)
  • laminin (2)
  • measure (15)
  • motor activity (1)
  • motor function (15)
  • young adult (1)
  • Sizes of these terms reflect their relevance to your search.

    To investigate the responsiveness of the motor function measure (MFM) and determine the minimal clinically important difference (MCID) in individuals with 2 common types of congenital muscular dystrophy (CMD). Observational, prospective, single center, cohort study. National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). Individuals (N=44) with collagen VI-related dystrophies (COL6-RD, n=23) and 21 individuals laminin alpha2-related muscular dystrophy (LAMA2-RD, n=21) enrolled in a 4-year longitudinal natural history study. Not applicable. Responsiveness of the MFM-32 and the Rasch-scaled MFM-25 and the MCID of the MFM-32 determined from a patient-reported anchor with 2 different methods, within-patient and between-patient. The original MFM-32 and Rasch-scaled MFM-25 performed similarly overall in both the COL6-RD and LAMA2-RD populations, with all subscores (D1, standing and transfers; D2, axial and proximal; D3, distal) showing a significant decrease over time, except MFM D1 and D3 for LAMA2-RD. The MFM D1 subscore was the most sensitive to change for ambulant individuals, whereas the MFM D2 subscore was the most sensitive to change for nonambulant individuals. The MCID for the MFM-32 total score was calculated as 2.5 and 3.9 percentage points according to 2 different methods. The MFM showed strong responsiveness in individuals with LAMA2-RD and COL6-RD. Because a floor effect was identified more prominently with the Rasch-Scaled MFM-25, the use of the original MFM-32 as a quantitative variable with the assumption of scale linearity appears to be a good compromise. When designing clinical trials in congenital muscular dystrophies, the use of MCID for MFM should be considered to determine if a given intervention effects show not only a statistically significant change but also a clinically meaningful change. Copyright © 2020 American Congress of Rehabilitation Medicine. All rights reserved.


    Laure Le Goff, Katherine G Meilleur, Gina Norato, Pascal Rippert, Minal Jain, Margaret Fink, A Reghan Foley, Melissa Waite, Sandra Donkervoort, Carsten G Bönnemann, Carole Vuillerot. Responsiveness and Minimal Clinically Important Difference of the Motor Function Measure in Collagen VI-Related Dystrophies and Laminin Alpha2-Related Muscular Dystrophy. Archives of physical medicine and rehabilitation. 2021 Apr;102(4):604-610

    Expand section icon Mesh Tags

    PMID: 33166523

    View Full Text